HCP, Inc. (HCP) Expected to Post Quarterly Sales of $452.10 Million
Equities analysts predict that HCP, Inc. (NYSE:HCP) will announce $452.10 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for HCP’s earnings. The highest sales estimate is $459.20 million and the lowest is $443.21 million. HCP reported sales of $654.27 million in the same quarter last year, which indicates a negative year-over-year growth rate of 30.9%. The company is expected to report its next earnings results on Tuesday, November 7th.
On average, analysts expect that HCP will report full-year sales of $452.10 million for the current financial year, with estimates ranging from $1.85 billion to $1.92 billion. For the next financial year, analysts anticipate that the company will report sales of $1.88 billion per share, with estimates ranging from $1.82 billion to $1.98 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for HCP.
HCP (NYSE:HCP) last announced its earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, topping the consensus estimate of $0.47 by $0.01. HCP had a net margin of 32.16% and a return on equity of 9.96%. The company had revenue of $458.90 million during the quarter, compared to analysts’ expectations of $456.29 million. During the same period last year, the company posted $0.71 earnings per share. The business’s revenue for the quarter was down 14.8% on a year-over-year basis.
A number of analysts have recently commented on HCP shares. UBS AG raised HCP from an “underperform” rating to an “outperform” rating in a research note on Wednesday, June 14th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $31.00 price target on shares of HCP in a research note on Friday, July 14th. BMO Capital Markets reaffirmed a “hold” rating and issued a $32.00 price target on shares of HCP in a research note on Wednesday, September 6th. BidaskClub cut HCP from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Finally, Mizuho reaffirmed a “neutral” rating on shares of HCP in a research note on Wednesday, June 28th. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $32.84.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Daily Political and is the property of of Daily Political. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.dailypolitical.com/2017/09/14/hcp-inc-hcp-expected-to-post-quarterly-sales-of-452-10-million.html.
Shares of HCP (NYSE HCP) traded up 0.24% on Monday, hitting $29.54. 6,048,897 shares of the company’s stock traded hands. The company has a market cap of $13.85 billion, a price-to-earnings ratio of 20.14 and a beta of 0.38. The firm’s 50-day moving average price is $29.95 and its 200 day moving average price is $31.09. HCP has a 1-year low of $27.61 and a 1-year high of $36.16.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 22nd. Stockholders of record on Monday, August 7th were issued a dividend of $0.37 per share. The ex-dividend date of this dividend was Thursday, August 3rd. This represents a $1.48 annualized dividend and a dividend yield of 5.01%. HCP’s dividend payout ratio is 102.07%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of HCP by 2.4% during the first quarter. Vanguard Group Inc. now owns 67,505,742 shares of the real estate investment trust’s stock valued at $2,111,579,000 after acquiring an additional 1,557,716 shares in the last quarter. BlackRock Inc. increased its holdings in shares of HCP by 1.3% during the second quarter. BlackRock Inc. now owns 46,580,421 shares of the real estate investment trust’s stock valued at $1,488,710,000 after acquiring an additional 599,578 shares in the last quarter. State Street Corp increased its holdings in shares of HCP by 0.3% during the second quarter. State Street Corp now owns 27,363,119 shares of the real estate investment trust’s stock valued at $874,524,000 after acquiring an additional 74,972 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of HCP by 2.3% during the second quarter. JPMorgan Chase & Co. now owns 23,442,708 shares of the real estate investment trust’s stock valued at $749,230,000 after acquiring an additional 521,915 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of HCP by 6.9% during the second quarter. Daiwa Securities Group Inc. now owns 10,610,722 shares of the real estate investment trust’s stock valued at $339,119,000 after acquiring an additional 687,228 shares in the last quarter. Hedge funds and other institutional investors own 89.75% of the company’s stock.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.